XTLB · Xtl Biopharmaceuticals Ltd · Holdings
Market Cap
$6.29M
Shares
2.46M
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Holders: 2
Total Value: $17,343
Total Shares: 6,353
Institutional Ownership Trend
26 quarters
Holder Concentration
Across 2 13F filers · Δ vs Mar 31, 2026Top Holder
98.0%
+29.6 pts
Top 5
100.0%
+0.0 pts
Top 10
100.0%
0.0 pts
HHI
9,614
Highly concentrated+4,510
Quarterly Activity
vs Mar 31, 2026
New
1
Increased
1
Decreased
0
Sold Out
5
Unchanged
0
Holder count:
-4
Institutional value:
-90.1%
Shares held:
-91.3%
Top Buyers
vs Mar 31, 2026| Institution | Added | Now Holds | Open |
|---|---|---|---|
| Mega RHUMBLINE ADVISERS | +241 | 6,228 |
Top Sellers
vs Mar 31, 2026No qualifying movers this quarter.
Top New Positions
vs Mar 31, 2026| Institution | Acquired | Value (USD) | Open |
|---|---|---|---|
| Mega UBS Group AG | 125 | $341 |
Top Sold-Out Positions
vs Mar 31, 2026| Institution | Previously Held | Last Value (USD) | Open |
|---|---|---|---|
| Small Noked Israel Ltd | 49,722 | $119,830 | |
| Small SmartHarvest Portfolios, LLC | 13,351 | $32,175 | |
| Mid GAMMA Investing LLC | 3,388 | $8,165 | |
| Mid Tower Research Capital LLC (TRC) | 244 | $588 | |
| Mega MORGAN STANLEY | 10 | $24 |
| Holder | Value (USD) | % of 13F | Shares | Type | Filed | Open |
|---|---|---|---|---|---|---|
| Mega RHUMBLINE ADVISERS | $17,002 | 98.03% | 6,228 | Shares | 2026-08-12 | |
| Mega UBS Group AG | $341 | 1.97% | 125 | Shares | 2026-08-13 |